会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明授权
    • Therapeutic agents useful for treating pain
    • 用于治疗疼痛的治疗剂
    • US07279493B2
    • 2007-10-09
    • US10607563
    • 2003-06-27
    • Donald J. KyleQun SunLaykea TafesseChongwu ZhangXiaoming Zhou
    • Donald J. KyleQun SunLaykea TafesseChongwu ZhangXiaoming Zhou
    • C07D277/04A61K43/80
    • C07D213/74C07D213/85C07D237/20C07D239/42C07D241/20C07D285/06C07D333/16
    • A compound of formula: wherein A, Ar, R3, R6, and m are disclosed herein, or a pharmaceutically acceptable salt thereof (a “Cyanoiminopiperazine Compound”), compositions comprising an effective amount of a Cyanoiminopiperazine Compound, and methods for treating or preventing pain, urinary incontinence, an ulcer, inflammatory-bowel disease, irritable-bowel syndrome, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia or depression in an animal comprising administering to an animal in need thereof an effective amount of a Cyanoiminopiperazine Compound are disclosed.
    • 式中的化合物:其中A,Ar,R 3,R 6和m在本文中公开,或其药学上可接受的盐(“氰基亚氨基哌嗪化合物”), 包含有效量的氰基亚氨基哌嗪化合物的组合物,治疗或预防疼痛,尿失禁,溃疡,炎性肠病,肠易激综合征,成瘾性疾病,帕金森病,帕金森综合征,焦虑症,癫痫,中风, 包括给予一个或多个癫痫发作,瘙痒症状,精神病,认知障碍,记忆缺陷,限制性脑功能,亨廷顿氏舞蹈病,肌萎缩性侧索硬化,痴呆,视网膜病变,肌肉痉挛,偏头痛,呕吐,运动障碍或抑郁症 公开了有效量的氰酰亚胺哌嗪化合物的需要动物。
    • 13. 发明申请
    • Therapeutic agents useful for treating pain
    • 用于治疗疼痛的治疗剂
    • US20060199824A1
    • 2006-09-07
    • US11337271
    • 2006-01-20
    • Qun SunKate WenXiaoming Zhou
    • Qun SunKate WenXiaoming Zhou
    • A61K31/506A61K31/497A61K31/501A61K31/4545A61K31/454C07D417/02C07D413/02C07D403/02C07D401/02
    • C07D417/14C07D401/04
    • Piperidine Compounds; compositions comprising a Piperidine Compound; and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Piperidine Compound are disclosed. In one embodiment, the Piperidine Compound has the formula: and pharmaceutically acceptable salts thereof, wherein Ar1, Ar2, X, R3, R4, and m are as disclosed herein.
    • 哌啶化合物; 包含哌啶化合物的组合物; 以及用于治疗或预防疼痛,UI,溃疡,IBD,IBS,成瘾性障碍,帕金森病,帕金森综合征,焦虑,癫痫,中风,癫痫发作,瘙痒症状,精神病,认知障碍,记忆缺陷,受限制 脑功能,亨廷顿舞蹈病,肌萎缩性侧索硬化,痴呆,视网膜病变,肌肉痉挛,偏头痛,呕吐,运动障碍或抑郁症,包括向有需要的动物施用有效量的哌啶化合物。 在一个实施方案中,哌啶化合物具有下式:及其药学上可接受的盐,其中Ar 1,Ar 2,X,R 3, R 4,且m如本文所公开。
    • 14. 发明授权
    • Therapeutic agents useful for treating pain
    • 用于治疗疼痛的治疗剂
    • US08058292B2
    • 2011-11-15
    • US12786043
    • 2010-05-24
    • Donald J. KyleQun SunXiaoming Zhou
    • Donald J. KyleQun SunXiaoming Zhou
    • A61K31/4427C07D401/04C07D401/12
    • C07D401/04C07D401/12
    • The invention provides a compound of formula (I): (where R1, Q, A and R2 are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Pyridine-alkynyl Compound”); pharmaceutical compositions comprising an effective amount of a Pyridine-alkynyl Compound; and methods for treating or preventing a condition such as pain, urinary incontinence, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, a seizure, stroke, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia or depression in an animal comprising administering to an animal in need thereof an effective amount of a Pyridine-alkynyl Compound.
    • 本发明提供式(I)化合物:其中R 1,Q,A和R 2在本文中公开)或其药学上可接受的盐(“吡啶 - 炔基化合物”); 包含有效量的吡啶 - 炔基化合物的药物组合物; 以及用于治疗或预防诸如疼痛,尿失禁,成瘾性障碍,帕金森病,帕金森综合征,焦虑,癫痫,癫痫发作,中风,瘙痒症状,精神病,认知障碍,记忆缺陷,限制性脑功能 亨廷顿舞蹈病,肌萎缩性侧索硬化症,痴呆症,视网膜病变,肌肉痉挛,偏头痛,呕吐,运动障碍或抑郁症,包括向有需要的动物施用有效量的吡啶 - 炔基化合物。
    • 15. 发明申请
    • THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN
    • 治疗药物有用的治疗药物
    • US20100256111A1
    • 2010-10-07
    • US12786043
    • 2010-05-24
    • Donald J. KyleQun SunXiaoming Zhou
    • Donald J. KyleQun SunXiaoming Zhou
    • A61K31/4427C07D211/98C07D211/94A61K31/4545C07D401/12A61P13/00A61P21/00A61P25/00A61P29/00
    • C07D401/04C07D401/12
    • The invention provides a compound of formula (I): (where R1, Q, A and R2 are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Pyridine-alkynyl Compound”); pharmaceutical compositions comprising an effective amount of a Pyridine-alkynyl Compound; and methods for treating or preventing a condition such as pain, urinary incontinence, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, a seizure, stroke, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia or depression in an animal comprising administering to an animal in need thereof an effective amount of a Pyridine-alkynyl Compound.
    • 本发明提供式(I)化合物:其中R 1,Q,A和R 2在本文中公开)或其药学上可接受的盐(“吡啶 - 炔基化合物”); 包含有效量的吡啶 - 炔基化合物的药物组合物; 以及用于治疗或预防诸如疼痛,尿失禁,成瘾性障碍,帕金森病,帕金森综合征,焦虑,癫痫,癫痫发作,中风,瘙痒症状,精神病,认知障碍,记忆缺陷,限制性脑功能 亨廷顿舞蹈病,肌萎缩性侧索硬化症,痴呆症,视网膜病变,肌肉痉挛,偏头痛,呕吐,运动障碍或抑郁症,包括向有需要的动物施用有效量的吡啶 - 炔基化合物。